Paper41041069
Hot-spot empowered gold nanoparticles for theranostics in breast cancer.
Tian M and 4 others. Theranostics, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Hot-spot empowered gold nanoparticles for theranostics in breast cancer. Papers, record 41041069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41041069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Gold | Major topic |
| Theranostic Nanomedicine | Major topic |
| Metal Nanoparticles | Major topic |
| Humans | |
| Female | |
| Photochemotherapy | |
| Drug Delivery Systems | |
| Animals | |
| Photothermal Therapy |
Source PubMed
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38062330 | A review on selenium and gold nanoparticles combined photodynamic and photothermal prostate cancer tumors ablation. | Discov Nano | 2023 | https://conductscience.org/library/papers/38062330 | PubMed |
| 2 | 39017700 | Artificial intelligence-based plasma exosome label-free SERS profiling strategy for early lung cancer detection. | Anal Bioanal Chem | 2024 | https://conductscience.org/library/papers/39017700 | PubMed |
| 3 | 39152194 | Innovation and challenges of artificial intelligence technology in personalized healthcare. | Sci Rep | 2024 | https://conductscience.org/library/papers/39152194 | PubMed |
| 4 | 37534056 | Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37534056 | PubMed |
| 5 | 36931265 | Deciphering breast cancer: from biology to the clinic. | Cell | 2023 | https://conductscience.org/library/papers/36931265 | PubMed |
| 6 | 30460281 | Microfluidics: Rapid Diagnosis for Breast Cancer. | Nanomicro Lett | 2016 | https://conductscience.org/library/papers/30460281 | PubMed |
| 7 | 32735811 | Polymer nanomedicines. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32735811 | PubMed |
| 8 | 29774071 | Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device. | Theranostics | 2018 | https://conductscience.org/library/papers/29774071 | PubMed |
| 9 | 32036302 | Advances in nanomaterials for photodynamic therapy applications: Status and challenges. | Biomaterials | 2020 | https://conductscience.org/library/papers/32036302 | PubMed |
| 10 | 31566198 | Synthesis of tunable DNA-directed trepang-like Au nanocrystals for imaging application. | Nanoscale | 2019 | https://conductscience.org/library/papers/31566198 | PubMed |
| 11 | 39040452 | Recent progress in Surface-Enhanced Raman Spectroscopy detection of biomarkers in liquid biopsy for breast cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39040452 | PubMed |
| 12 | 33533597 | DNA-Mediated Au-Au Dimer-Based Surface Plasmon Coupling Electrochemiluminescence Sensor for BRCA1 Gene Detection. | Anal Chem | 2021 | https://conductscience.org/library/papers/33533597 | PubMed |
| 13 | 31006932 | Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/31006932 | PubMed |
| 14 | 34727233 | Cancer nanotechnology: current status and perspectives. | Nano Converg | 2021 | https://conductscience.org/library/papers/34727233 | PubMed |
| 15 | 33524960 | Exploiting gold nanoparticles for diagnosis and cancer treatments. | Nanotechnology | 2021 | https://conductscience.org/library/papers/33524960 | PubMed |
| 16 | 35890217 | Stimuli-Responsive Gold Nanocages for Cancer Diagnosis and Treatment. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35890217 | PubMed |
| 17 | 22591323 | Chiral nanocrystals: plasmonic spectra and circular dichroism. | Nano Lett | 2012 | https://conductscience.org/library/papers/22591323 | PubMed |
| 18 | 21723891 | Inorganic nanoparticles for cancer imaging and therapy. | J Control Release | 2011 | https://conductscience.org/library/papers/21723891 | PubMed |
| 19 | 31472191 | Plasmonic gold nanoparticles: Optical manipulation, imaging, drug delivery and therapy. | J Control Release | 2019 | https://conductscience.org/library/papers/31472191 | PubMed |
| 20 | 35319200 | Ultrasensitive SERS Analysis of Liquid and Gaseous Putrescine and Cadaverine by a 3D-Rosettelike Nanostructure-Decorated Flexible Porous Substrate. | Anal Chem | 2022 | https://conductscience.org/library/papers/35319200 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41041069
GET https://conductscience.org/api/papers/v1/41041069/references?page=2